www.otcmarkets.com/stock/RIGH/news
News
Beiträge: 169
Zugriffe: 14.363 / Heute: 16
Zugriffe: 14.363 / Heute: 16
|
Werbung
Entdecke die beliebtesten ETFs von Xtrackers
Xtrackers MSCI Japan UCITS ETF 1D
Perf. 12M: +155,87%
Xtrackers MSCI Pakistan Swap UCITS ETF 1C
Perf. 12M: +68,36%
Xtrackers Artificial Intelligence and Big Data UCITS ETF 1C
Perf. 12M: +57,05%
Xtrackers S&P 500 2x Leveraged Daily Swap UCITS ETF 1C
Perf. 12M: +53,56%
Xtrackers MSCI USA Communication Services UCITS ETF 1D
Perf. 12M: +51,49%
www.BGMedTech.com
www.otcmarkets.com/stock/RIGH/news
www.otcmarkets.com/stock/RIGH/news
www.bgmedtech.com/
"Soon, very soon... Final Configuration in Progress... Please Stand By"
"Soon, very soon... Final Configuration in Progress... Please Stand By"
BG Medical Technologies, Inc. is a publicly traded company under the symbol, OTC:RIGH (symbol change pending).
hat den kurs aber leider nicht beflügelt.
hat den kurs aber leider nicht beflügelt.
BG Medical Technologies (OTC: RIGH) has announced development of a USB-enabled diagnostic support device that will facilitate patients suffering from critical illnesses such as cancer, to match the most effective plant variants for physician-recommended medical marijuana treatments. The device will collect patient data in a non-invasive manner by detecting subtle shifts in the patient's physiology and then upload encrypted data to HIPAA-compliant servers for further analysis and physician review. Physicians will interact with patients and data history through a bundled video conferencing application. This will offer patients the ability to discreetly pursue medical marijuana treatment from the privacy of their home. For states with telemedicine restrictions, services will be made available for use within physician offices. This system also seeks to improve medical marijuana treatment programs by involving physicians more than once per year to better evaluate treatment effectiveness and applicability.
The diagnostic support system works in tandem with BG Medical's BudGenius.com laboratory research and ongoing data collection to identify marijuana strains that present the most beneficial ratios of medicinal compounds that are likely to best serve the patient's needs. Medicine locator services will also be used to locate cannabis strains currently available within the patient's travel radius. BudGenius services will continue to be expanded with new features to support the diagnostic system development, and will be further enhanced with new technology partnerships. BG Medical has stated that this announcement fulfills another component of their "natural medicine trifecta", an empirical data approach to administering natural medical marijuana treatments, as detailed in their product strategy guide.
"While our competitors are seeking to create pharmaceuticals that divide and isolate the helpful compounds in cannabis, we will continue to focus on systems that support treatments with organically developed medicines that are genetically predisposed to treat specific ailments in their natural form," adds Angel Stanz, CEO. "In the shadow of a failed healthcare system rife with expensive and toxic treatments, we believe the convergence of nature and Internet technologies will form the future of affordable preventative and curative medicine."
The USB hardware device is based upon technologies previously authorized by the FDA to enter clinical trials for determining its effectiveness in breast cancer diagnosis. BG Medical Technologies will seek FDA approval of the final hardware implementation as a diagnostic support device.
About BG Medical Technologies
BG Medical Technologies develops ancillary support services for medical cannabis patients and professionals, including its flagship medical marijuana research laboratory and website portal, BudGenius.com. BG Medical Technologies, Inc. currently trades under the symbol OTC:RIGH. Symbol and name change pending. www.BgMedTech.com
About BudGenius.com
BudGenius.com is a social networking website, and leading provider of medical marijuana testing services located in California. In addition to cannabis safety screenings, BudGenius provides a unique rating system to assist patients in selecting marijuana strains more likely to efficiently treat specific medical conditions.
www.BudGenius.com
BG Medical Technologies and its companies do not sell, grow, harvest, cultivate, nor distribute medical cannabis. None of the statements made herein have been evaluated by the FDA, and therefore should not be construed as dispensing medical advice or making claims regarding the cure of diseases.
The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
Contact:Angel Stanz Chief Executive Officer pr(at)bgmedtech(dot)com(855) 723-3283
SOURCE BG Medical Technologies, Inc.
The diagnostic support system works in tandem with BG Medical's BudGenius.com laboratory research and ongoing data collection to identify marijuana strains that present the most beneficial ratios of medicinal compounds that are likely to best serve the patient's needs. Medicine locator services will also be used to locate cannabis strains currently available within the patient's travel radius. BudGenius services will continue to be expanded with new features to support the diagnostic system development, and will be further enhanced with new technology partnerships. BG Medical has stated that this announcement fulfills another component of their "natural medicine trifecta", an empirical data approach to administering natural medical marijuana treatments, as detailed in their product strategy guide.
"While our competitors are seeking to create pharmaceuticals that divide and isolate the helpful compounds in cannabis, we will continue to focus on systems that support treatments with organically developed medicines that are genetically predisposed to treat specific ailments in their natural form," adds Angel Stanz, CEO. "In the shadow of a failed healthcare system rife with expensive and toxic treatments, we believe the convergence of nature and Internet technologies will form the future of affordable preventative and curative medicine."
The USB hardware device is based upon technologies previously authorized by the FDA to enter clinical trials for determining its effectiveness in breast cancer diagnosis. BG Medical Technologies will seek FDA approval of the final hardware implementation as a diagnostic support device.
About BG Medical Technologies
BG Medical Technologies develops ancillary support services for medical cannabis patients and professionals, including its flagship medical marijuana research laboratory and website portal, BudGenius.com. BG Medical Technologies, Inc. currently trades under the symbol OTC:RIGH. Symbol and name change pending. www.BgMedTech.com
About BudGenius.com
BudGenius.com is a social networking website, and leading provider of medical marijuana testing services located in California. In addition to cannabis safety screenings, BudGenius provides a unique rating system to assist patients in selecting marijuana strains more likely to efficiently treat specific medical conditions.
www.BudGenius.com
BG Medical Technologies and its companies do not sell, grow, harvest, cultivate, nor distribute medical cannabis. None of the statements made herein have been evaluated by the FDA, and therefore should not be construed as dispensing medical advice or making claims regarding the cure of diseases.
The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
Contact:Angel Stanz Chief Executive Officer pr(at)bgmedtech(dot)com(855) 723-3283
SOURCE BG Medical Technologies, Inc.
29.2.12
TeleHealthcare Systems from BG Medical Technologies to Reduce Patient Healthcare Costs and Improve Lives
BG Medical Technologies, Inc. (OTC:RIGH) is set to engage an $11 billion dollar tele-healthcare market in addition to the projected $14 billion dollar medical marijuana market, with Internet and smartphone applications to support growing trends of natural medicine and wellness care.
Healthcare costs in the United States are some of the highest in the world leaving many Americans uninsured, under-insured, or living in communities without access to affordable care. This problem worsens as US healthcare costs continue to rise each year. For those who can afford healthcare, new problems are introduced. The Centers for Disease Control and Prevention report that half of all Americans will be diagnosed with a mental illness during their lifetime. Celebrity prescription drug deaths dominate media headlines, and pharmaceutical-related drug deaths now outnumber traffic fatalities in the United States.
BG Medical Technologies is introducing safe and affordable alternatives to traditional healthcare with Internet-based applications that support nutraceutical and medical marijuana treatments. Recently the company announced development of a diagnostic device that is designed to provide physicians with data to chart medical marijuana effectiveness over time. These systems will be made available to marijuana-recommending doctors and will include the ability to instantly link diagnostic data to a remote network of naturopathy doctors for further on-site and remote patient care. Patients will be apprised of additional diagnostic findings and be given the option to pursue adjunct natural therapies in addition to medical marijuana treatments.
"We've all had the experience of having our car serviced for a noticeable problem only to learn that once the mechanic examined under the hood, more parts were wearing out that endangered our safety," stated Angel Stanz, CEO. "We are making this type of preventative maintenance available to everyone. This is expected to save tens of thousands of dollars in out-of-pocket healthcare expenses per patient."
BG Medical is designing these systems to reduce patient costs while providing additional shared revenue to participating medical marijuana doctors, caregivers, and licensed naturopath physicians. More information on how this technology will interact with patients and doctors can be found in the company's articles section of their corporate website.
About BG Medical Technologies
BG Medical Technologies develops ancillary support services for medical cannabis patients and professionals, including its flagship medical marijuana research laboratory and website portal, BudGenius.com. BG Medical Technologies, Inc. currently trades under the symbol OTC:RIGH. Symbol and name change pending. www.BgMedTech.com
BG Medical Technologies and its companies do not sell, grow, harvest, cultivate, nor distribute medical cannabis. None of the statements made herein have been evaluated by the FDA, and therefore should not be construed as dispensing medical advice or making claims regarding the cure of diseases.
The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
Contact: Angel Stanz Chief Executive Officer pr(at)bgmedtech(dot)com(855) 723-3283
SOURCE BG Medical Technologies, Inc.
TeleHealthcare Systems from BG Medical Technologies to Reduce Patient Healthcare Costs and Improve Lives
BG Medical Technologies, Inc. (OTC:RIGH) is set to engage an $11 billion dollar tele-healthcare market in addition to the projected $14 billion dollar medical marijuana market, with Internet and smartphone applications to support growing trends of natural medicine and wellness care.
Healthcare costs in the United States are some of the highest in the world leaving many Americans uninsured, under-insured, or living in communities without access to affordable care. This problem worsens as US healthcare costs continue to rise each year. For those who can afford healthcare, new problems are introduced. The Centers for Disease Control and Prevention report that half of all Americans will be diagnosed with a mental illness during their lifetime. Celebrity prescription drug deaths dominate media headlines, and pharmaceutical-related drug deaths now outnumber traffic fatalities in the United States.
BG Medical Technologies is introducing safe and affordable alternatives to traditional healthcare with Internet-based applications that support nutraceutical and medical marijuana treatments. Recently the company announced development of a diagnostic device that is designed to provide physicians with data to chart medical marijuana effectiveness over time. These systems will be made available to marijuana-recommending doctors and will include the ability to instantly link diagnostic data to a remote network of naturopathy doctors for further on-site and remote patient care. Patients will be apprised of additional diagnostic findings and be given the option to pursue adjunct natural therapies in addition to medical marijuana treatments.
"We've all had the experience of having our car serviced for a noticeable problem only to learn that once the mechanic examined under the hood, more parts were wearing out that endangered our safety," stated Angel Stanz, CEO. "We are making this type of preventative maintenance available to everyone. This is expected to save tens of thousands of dollars in out-of-pocket healthcare expenses per patient."
BG Medical is designing these systems to reduce patient costs while providing additional shared revenue to participating medical marijuana doctors, caregivers, and licensed naturopath physicians. More information on how this technology will interact with patients and doctors can be found in the company's articles section of their corporate website.
About BG Medical Technologies
BG Medical Technologies develops ancillary support services for medical cannabis patients and professionals, including its flagship medical marijuana research laboratory and website portal, BudGenius.com. BG Medical Technologies, Inc. currently trades under the symbol OTC:RIGH. Symbol and name change pending. www.BgMedTech.com
BG Medical Technologies and its companies do not sell, grow, harvest, cultivate, nor distribute medical cannabis. None of the statements made herein have been evaluated by the FDA, and therefore should not be construed as dispensing medical advice or making claims regarding the cure of diseases.
The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
Contact: Angel Stanz Chief Executive Officer pr(at)bgmedtech(dot)com(855) 723-3283
SOURCE BG Medical Technologies, Inc.
hastn du für eine WKN vorliegen? ich kann leider unter der WKN keine Orders erfassen....
Danke!
Danke!
BG Medical Technologies Completes Process to Upgrade OTC Markets Listing
14:35 16.10.12
PR Newswire
LOS ANGELES, Oct. 16, 2012
LOS ANGELES, Oct. 16, 2012 /PRNewswire/ -- BG Medical Technologies, Inc. (OTC: RIGH) is pleased to announce that it has submitted all necessary filings and the accompanying attorney opinion letter required to fully restore the Company to "Current Information" on OTC Markets. The new status is expected to be displayed within several days.
Q1 and Q2 financials have been resubmitted to reflect an increased level of disclosure congruent with OTC Market Group's Guidelines for Providing Adequate Current Information. The Company has also obtained new accounting and legal firms, replacing those associated with previous management and past filings for the public entity.
"This forward momentum represents our ongoing commitment to completing the steps associated with the reverse merger from earlier this year," stated CEO Angel Stanz. "Our upgraded team is strongly committed to regulatory compliance and will be assisting us through the planned audit process and additional filings."
About BG Medical Technologies
BG Medical Technologies develops technology and research software for the health industry with a focus on patient solutions for natural and herbal treatments, including medical cannabis. The Company collects data through a network of proprietary software, utilized by patients, retail operators, and medical professionals. The Company's current flagship product, BudGenius.com, is a social web platform designed to assist cannabis patients in selecting regionally available medicine that is paired to their needs. The Company operates an analytical chemistry laboratory designed for natural medicine study, utilized to determine potency and safety guidance for patients and medicine manufacturers.
For more information please visit:
www.BgMedTech.com
www.BudGenius.com
BG Medical and its companies do not sell, grow, harvest, cultivate, nor distribute medical cannabis.
The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
Contact:
Angel Stanz
Chief Executive Officer
pr(at)bgmedtech(dot)com
(855) 723-3283
SOURCE BG Medical Technologies, Inc.
Quelle: PR Newswire
14:35 16.10.12
PR Newswire
LOS ANGELES, Oct. 16, 2012
LOS ANGELES, Oct. 16, 2012 /PRNewswire/ -- BG Medical Technologies, Inc. (OTC: RIGH) is pleased to announce that it has submitted all necessary filings and the accompanying attorney opinion letter required to fully restore the Company to "Current Information" on OTC Markets. The new status is expected to be displayed within several days.
Q1 and Q2 financials have been resubmitted to reflect an increased level of disclosure congruent with OTC Market Group's Guidelines for Providing Adequate Current Information. The Company has also obtained new accounting and legal firms, replacing those associated with previous management and past filings for the public entity.
"This forward momentum represents our ongoing commitment to completing the steps associated with the reverse merger from earlier this year," stated CEO Angel Stanz. "Our upgraded team is strongly committed to regulatory compliance and will be assisting us through the planned audit process and additional filings."
About BG Medical Technologies
BG Medical Technologies develops technology and research software for the health industry with a focus on patient solutions for natural and herbal treatments, including medical cannabis. The Company collects data through a network of proprietary software, utilized by patients, retail operators, and medical professionals. The Company's current flagship product, BudGenius.com, is a social web platform designed to assist cannabis patients in selecting regionally available medicine that is paired to their needs. The Company operates an analytical chemistry laboratory designed for natural medicine study, utilized to determine potency and safety guidance for patients and medicine manufacturers.
For more information please visit:
www.BgMedTech.com
www.BudGenius.com
BG Medical and its companies do not sell, grow, harvest, cultivate, nor distribute medical cannabis.
The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
Contact:
Angel Stanz
Chief Executive Officer
pr(at)bgmedtech(dot)com
(855) 723-3283
SOURCE BG Medical Technologies, Inc.
Quelle: PR Newswire
weiß jemand wann RIGH wiedre bei Flatex gehandelt wird?
Hallo liebes Forum im Winterschlaf :)
Kann mir jemand verraten, welcher Broker diese Aktie überhaupt noch handelt?
Am besten noch an ihrer Heimatbörse.
Vielen Dank für die Mühe im voraus!
Viele Grüße
Versuchmachtklug
Kann mir jemand verraten, welcher Broker diese Aktie überhaupt noch handelt?
Am besten noch an ihrer Heimatbörse.
Vielen Dank für die Mühe im voraus!
Viele Grüße
Versuchmachtklug
Was ist hier los?
de.advfn.com/...=righ&p=0&t=16&dm=0&vol=1&
de.advfn.com/...=righ&p=0&t=16&dm=0&vol=1&
ihub rockt!!!
investorshub.advfn.com/RightSmile-Inc-RIGH-14521/
investorshub.advfn.com/RightSmile-Inc-RIGH-14521/
Verstehst du das warum es heute so ab geht.finde keine News oder etwas anderes warum wir so ein hohes Volumen haben.gruß
RIGH ~ ~ THE NEXT EXPLOSIVEN MJ STOCK ~ ~
Gruß
Gruß
www.BgMedTech.com
www.BudGenius.com
www.BudGenius.com
Verstehe den Zusammenhang nicht.bist du investiert in right
|
Neueste Beiträge aus dem Rightsmile Forum
| Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
2 | 168 | News | hallias | sena75 | 25.04.21 02:42 | |
| 4 | It is legalized ! | big_johnson | big_johnson | 08.02.12 14:11 |
